Kim S - Search Results

1

Phase I and pharmacokinetic study of intraperitoneal ormaplatin.

Plaxe SC, Braly PS, Freddo JL, McClay E, Christen RD, Kirmani S, Kim S, Heath D, Howell SB. Plaxe SC, et al. Among authors: kim s. Gynecol Oncol. 1993 Oct;51(1):72-7. doi: 10.1006/gyno.1993.1249. Gynecol Oncol. 1993. PMID: 8244179 Clinical Trial.

2

Pharmacokinetic study of intraperitoneal streptozotocin.

Goel R, McClay EF, Kirmani S, Kim S, Braly PF, Plaxe SC, Alcaraz J, Andrews PA, Reichman B, Markman M, et al. Goel R, et al. Among authors: kim s. Clin Invest Med. 1992 Oct;15(5):420-6. Clin Invest Med. 1992. PMID: 1458714

3

Intraperitoneal cisplatin-based chemotherapy for ovarian carcinoma.

Howell SB, Kirmani S, McClay EF, Kim S, Braly P, Plaxe S. Howell SB, et al. Among authors: kim s. Semin Oncol. 1991 Feb;18(1 Suppl 3):5-10. Semin Oncol. 1991. PMID: 2003227 Review.

4

Phase I and pharmacokinetic trial of intraperitoneal etoposide in combination with the multidrug-resistance-modulating agent dipyridamole.

Isonishi S, Kirmani S, Kim S, Plaxe SC, Braly PS, McClay EF, Howell SB. Isonishi S, et al. Among authors: kim s. J Natl Cancer Inst. 1991 May 1;83(9):621-6. doi: 10.1093/jnci/83.9.621. J Natl Cancer Inst. 1991. PMID: 2023280 Clinical Trial.

5

A phase II trial of intraperitoneal cisplatin and etoposide as salvage treatment for minimal residual ovarian carcinoma.

Kirmani S, Lucas WE, Kim S, Goel R, McVey L, Morris J, Howell SB. Kirmani S, et al. Among authors: kim s. J Clin Oncol. 1991 Apr;9(4):649-57. doi: 10.1200/JCO.1991.9.4.649. J Clin Oncol. 1991. PMID: 2066761 Clinical Trial.

6

A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial cancer.

Howell SB, Kirmani S, Lucas WE, Zimm S, Goel R, Kim S, Horton MC, McVey L, Morris J, Weiss RJ. Howell SB, et al. Among authors: kim s. J Clin Oncol. 1990 Jan;8(1):137-45. doi: 10.1200/JCO.1990.8.1.137. J Clin Oncol. 1990. PMID: 2295904

7

A phase II trial of intraperitoneal high-dose carboplatin and etoposide with granulocyte macrophage-colony stimulating factor support in patients with ovarian carcinoma.

McClay EF, Braly PD, Kirmani S, Plaxe SC, Kim S, McClay ME, Wilgus L, Howell SB. McClay EF, et al. Among authors: kim s. Am J Clin Oncol. 1995 Feb;18(1):23-6. doi: 10.1097/00000421-199502000-00005. Am J Clin Oncol. 1995. PMID: 7847254 Clinical Trial.

8

Phase I trial of cisplatin in combination with glutathione.

Plaxe S, Freddo J, Kim S, Kirmani S, McClay E, Christen R, Braly P, Howell S. Plaxe S, et al. Among authors: kim s. Gynecol Oncol. 1994 Oct;55(1):82-6. doi: 10.1006/gyno.1994.1252. Gynecol Oncol. 1994. PMID: 7959273 Clinical Trial.

9

A phase I trial of intraperitoneal carboplatin and etoposide with granulocyte macrophage colony stimulating factor support in patients with intraabdominal malignancies.

McClay EF, Braly PD, Kirmani S, Plaxe SC, McClay ME, Wilgus L, Kim S, Howell SB. McClay EF, et al. Among authors: kim s. Cancer. 1994 Jul 15;74(2):664-9. doi: 10.1002/1097-0142(19940715)74:2<664::aid-cncr2820740219>3.0.co;2-8. Cancer. 1994. PMID: 8033046 Clinical Trial.

10

A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancer.

Kirmani S, Braly PS, McClay EF, Saltzstein SL, Plaxe SC, Kim S, Cates C, Howell SB. Kirmani S, et al. Among authors: kim s. Gynecol Oncol. 1994 Sep;54(3):338-44. doi: 10.1006/gyno.1994.1220. Gynecol Oncol. 1994. PMID: 8088611 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124,193 results

Search Page

Filters